- Works count
- 445
- Citation count
- 39,394
- H-index
- 49
- i10-index
- 163
Research interests
Publications
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.58.3708
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.53.0105
Nivolumab plus Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1302369
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1200690
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1200694
Current projects
No projects listed.